An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome
- PMID: 34076874
- DOI: 10.1007/s43032-021-00641-z
An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a significant public health issue with diverse presentations, including reproductive, metabolic, and psychological disorders. Although problems with ovulation, metabolism, and hormonal imbalance can be pharmacologically improved, even the excellent quality of transferred embryos does not necessarily increase the pregnancy rate. Poor endometrial receptivity in women with PCOS perturbs endometrial decidualization and blastocyst implantation, increasing adverse pregnancy outcomes, such as miscarriage and poor embryonic development. The etiological and pathophysiological mechanisms involved in defective endometrial receptivity in women with PCOS have not been fully elucidated to date. Various contributing factors have been reported as primary causes of defective endometrial receptivity in women with PCOS, including metabolic alterations, inflammatory events, and some abnormally expressed endometrial molecular markers. However, few studies to date have investigated in depth the complex mechanisms underlying the compromised endometrial receptivity in women with PCOS. This article reviews recent reports mainly on metabolic alterations and some new endometrial molecular markers in order to collate the existing data and improve our understanding in this field. The aim was to discuss current novel insights on defective endometrial receptivity in women with PCOS in order to provide a theoretical basis for reducing adverse pregnancy outcomes and improving the live birth rate in PCOS.
Keywords: Decidualization; Endometrial molecular markers; Endometrial receptivity; Metabolic alterations; PCOS.
© 2021. Society for Reproductive Investigation.
References
-
- Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human reproduction (Oxford, England). 2018;33(9):1602–18. https://doi.org/10.1093/humrep/dey256 . - DOI
-
- Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clinica chimica acta; international journal of clinical chemistry. 2020;502:214–21. https://doi.org/10.1016/j.cca.2019.11.003 . - DOI - PubMed
-
- Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction (Oxford, England). 2016;31(12):2841–55. https://doi.org/10.1093/humrep/dew218 . - DOI
-
- Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Frontiers in bioscience (Elite edition). 2014;6:104–19. https://doi.org/10.2741/e695 . - DOI
-
- Kelley AS, Smith YR, Padmanabhan V. A narrative review of placental contribution to adverse pregnancy outcomes in women with polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism. 2019;104(11):5299–315. https://doi.org/10.1210/jc.2019-00383 . - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
